Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DS-1040B in acute ischemic stroke
2015-001824-43Phase 2Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing DS-1040B with Placebo (2 arms). Primary endpoint: Safety parameters. Started Jun 2015; status: completed.
02
Drugs
DS1040b
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2015-001824-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001824-43.